Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

14.50
Delayed Data
As of Sep 30
 +0.30 / +2.11%
Today’s Change
10.44
Today|||52-Week Range
25.20
-32.53%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cellular Biomedicine Group Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +10.34% increase from the last price of 14.50.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Cellular Biomedicine Group Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
--
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually --

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.